• TheGlobal pandemic.
catalyst for scientific innovation
• globalisation and disease transmission. Double edged sword .
• Beyond the borders: International collaboration fight against COVID 19
• Global Hunt for vaccine
• Health care system under strain global perspective
• Role of Gavi
• COVID-19 Pandemic: A Global Health Crisis
• I. Systemic Weaknesses Exposed
• * Healthcare Infrastructure: * Supply Chain Disruptions:
* Government Preparedness and Response: Ineffective policy implementat . Public
Health System Failures
• II. The Impact on Healthcare Systems
Healthcare Worker Burnout:
Increased workload and stress. Financial Strain on Healthcare Institutions
Increased costs and reduced revenue
Mental health challenges
Disrupted Healthcare Services:
Delayed or cancelled elective procedures. . Limited access to routine care
* Global Effort for Vaccine Development:
* EU’s Strategy: The EU aims to secure vaccine supplies, adjust regulations, and
ensure equitable access.
* Criteria for Vaccine Manufacturer Selection: Key criteria include scientific
soundness, delivery capacity, cost-effectiveness, shared risk, and global access
commitment.
* Limitations in Current Practices: Current selection practices lack robustness in
identifying and analyzing decision criteria and their interdependencies.
* Proposed Methodology: The study proposes a methodology combining cognitive
mapping, DEMATEL, and the CI to improve the selection process.
The United Kingdom was the first country to approve the Pfizer-BioNTech COVID-19
vaccine on December 2, 2020.
MRNA technology
Rapid development
High efficiency
Global impact
US collaborated with countries like UK ,china, India, Russia, several EN
Role of Gavi
GAVI, or Gavi, the Vaccine Alliance, is a public-private partnership that aims to increase
access to immunization in developing countries:
Goal: Increase access to immunization in poor countries
The article criticizes GAVI’s use of the AMC to purchase PCVs, arguing it prioritizes
corporate profits over public health. It proposes global health and purpose alternative
strategies like supporting local vaccine production and strengthening health systems to
improve vaccine access and affordability in developing countries.
